Pro-inflammatory lung dendritic cells in stratified severe RSV bronchiolitis

分层严重 RSV 细支气管炎中的促炎肺树突状细胞

基本信息

  • 批准号:
    MR/K002589/1
  • 负责人:
  • 金额:
    $ 37.12万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2012
  • 资助国家:
    英国
  • 起止时间:
    2012 至 无数据
  • 项目状态:
    已结题

项目摘要

BACKGROUND: Respiratory syncytial virus (RSV) is worldwide the most common cause of a type of chest infections in babies and toddlers called bronchiolitis, which can cause severe disease and occasionally death. Vaccination or specific treatment is not available. Due to treatment costs and costs for the wider society (e.g. days lost at work for parents/ carers) RSV is responsible for a major financial burden. 2% of all babies in the UK have to be admitted to hospital with RSV bronchiolitis and some of them develop very severe and sometimes life threatening disease which causes breathing to fail. These babies require breathing support where a machine inflates their lungs. This is usually only required for a few days, but in a third of these very severe cases the disease fails to improve quickly making longer machine breathing support necessary. Breathing problems in RSV bronchiolitis are thought to be due to very severe inflammation of the small ends of the breathing tubes in the lung. The mechanisms that maintain this inflammation and delay improvement of disease are not well understood. Work in mouse models suggests that two types if immune cells have important roles in lung inflammation after RSV infection; one of these are called T cells and the other dendritic cells (DCs) which are the main activators of T cells. PILOT DATA: In a pilot study of infants with RSV bronchiolitis who were on machine breathing support, we have recently detected substantial numbers of DCs and T cells in small lung washes. Lung washes of infants with healthy uninfected lungs do not contain these cells. HYPOTHESIS AND PROJECT PLaN: We hypothesise that activated lung DCs and T cells which can lead to inflammation, are responsible for continuing inflammation and the delay in improvement of disease in babies with longer lasting severe RSV bronchiolitis. We will take small lung washes from babies with severe RSV disease who are on machine breathing support comparing those who only need this support briefly to those who require it for a longer time. In the lung washes we will count DCs and different groups of T cells, measure the activation of DCs and their ability to activate T cells and we will find out if signal substances in the wash fluid are able to cause the development and / or activation of DCs. We will then use the mouse model of RSV infection to prove or disprove that DCs are required to maintain inflammation by taking DCs out of the mouse and then replacing them. OUTLOOK: If we find that activated lung DCs and associated T cells are responsible for maintaining inflammation and delaying improvement of disease in severe long lasting RSV bronchiolitis, these studies will identify lung DCs as a promising target for the development of new anti-inflammatory therapies for this condition. In addition numbers and properties of lung DC may also be useful as a marker to predict delayed resoltion of severe RSV disease.
背景:呼吸道合胞病毒(RSV)是世界范围内引起婴幼儿肺部感染的最常见原因,称为毛细支气管炎,可导致严重疾病和偶尔死亡。没有疫苗接种或特殊治疗。由于治疗费用和更广泛社会的费用(例如父母/照顾者的工作损失天数),呼吸道合流病毒造成了重大的经济负担。在英国,有2%的婴儿因呼吸道合胞病毒细支气管炎而住院,其中一些人会发展成非常严重的疾病,有时甚至会危及生命,导致呼吸衰竭。这些婴儿需要呼吸支持,机器给他们的肺充气。这通常只需要几天,但在这些非常严重的病例中,有三分之一的疾病没有迅速改善,因此需要更长时间的机器呼吸支持。呼吸道合胞病毒细支气管炎的呼吸问题被认为是由于肺部呼吸管小端非常严重的炎症。维持这种炎症和延缓疾病改善的机制尚不清楚。小鼠模型的研究表明,两种类型的免疫细胞在RSV感染后的肺部炎症中起重要作用;其中一种叫做T细胞,另一种叫做树突状细胞(dc),它们是T细胞的主要激活剂。试点数据:在一项针对呼吸道合胞病毒毛细支气管炎患儿的试点研究中,我们最近在小肺洗液中检测到大量的dc和T细胞。健康未感染肺的婴儿洗肺不含这些细胞。假设和项目计划:我们假设激活的肺dc和T细胞可导致炎症,是持续炎症和延迟持续较长时间的严重RSV细支气管炎婴儿疾病改善的原因。我们将对患有严重呼吸道合胞病毒疾病的使用机器呼吸支持的婴儿进行小肺冲洗,比较那些只需要短暂呼吸支持的婴儿和那些需要较长时间呼吸支持的婴儿。在肺洗液中,我们将计数dc和不同组的T细胞,测量dc的激活和它们激活T细胞的能力,我们将发现洗液中的信号物质是否能够导致dc的发展和/或激活。然后,我们将使用RSV感染的小鼠模型来证明或反驳dc是维持炎症所必需的,方法是将dc从小鼠中取出,然后替换它们。展望:如果我们发现激活的肺dc和相关T细胞在严重的持久RSV细支气管炎中负责维持炎症和延迟疾病的改善,这些研究将确定肺dc作为开发新的抗炎疗法的有希望的靶点。此外,肺DC的数量和性质也可作为预测严重RSV疾病延迟消退的标志物。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pediatric Pulmonology year in review 2015: Part 1.
2015 年儿科肺病学回顾:第 1 部分。
  • DOI:
    10.1002/ppul.23423
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Auten R
  • 通讯作者:
    Auten R
Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
病毒模拟聚 (I:C) 减弱气道上皮 T 细胞抑制能力:对哮喘的影响。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jürgen Schwarze其他文献

Deep multiomic profiling reveals molecular signatures that underpin preschool wheeze and asthma
深度多组学分析揭示了支撑学龄前儿童喘息和哮喘的分子特征
  • DOI:
    10.1016/j.jaci.2024.08.017
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Matthew Macowan;Céline Pattaroni;Katie Bonner;Roxanne Chatzis;Carmel Daunt;Mindy Gore;Adnan Custovic;Michael D. Shields;Ultan F. Power;Jonathan Grigg;Graham Roberts;Peter Ghazal;Jürgen Schwarze;Steve Turner;Andrew Bush;Sejal Saglani;Clare M. Lloyd;Benjamin J. Marsland
  • 通讯作者:
    Benjamin J. Marsland
Neue Nomenklatur allergischer Erkrankungen nach EAACI-Standard
  • DOI:
    10.1007/s15007-024-6331-0
  • 发表时间:
    2024-09-16
  • 期刊:
  • 影响因子:
    1.000
  • 作者:
    Marek Jutel;Markus Ollert;Stefan Vieths;Jürgen Schwarze;Ioana Agache;Cezmi A. Akdis;Oliver Pfaar;Ludger Klimek
  • 通讯作者:
    Ludger Klimek
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis
真实世界中尼赛珠单抗、呼吸道合胞病毒母体疫苗以及老年人呼吸道合胞病毒疫苗的应用:一项系统综述和荟萃分析
  • DOI:
    10.1016/j.eclinm.2025.103281
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    10.000
  • 作者:
    Daira Trusinska;Bohee Lee;Sohail Ferdous;Harley H.Y. Kwok;Becky Gordon;Junyi Gao;Liantao Ma;Hanbiao Xiong;Sir Aziz Sheikh;Jürgen Schwarze;John Busby;Cheryl Gibbons;Simon B. Drysdale;Sir Lewis Ritchie;Thomas Williams;Ting Shi
  • 通讯作者:
    Ting Shi

Jürgen Schwarze的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jürgen Schwarze', 18)}}的其他基金

Prevention of severe RSV infection by a helminth-induced serum factor that elicits antiviral monocytes?
通过引起抗病毒单核细胞的蠕虫诱导血清因子来预防严重 RSV 感染?
  • 批准号:
    MR/T029668/1
  • 财政年份:
    2020
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Research Grant
Mechanisms of helminth induced antiviral immunity to RSV infection
蠕虫诱导RSV感染抗病毒免疫的机制
  • 批准号:
    MR/L008394/1
  • 财政年份:
    2014
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Research Grant

相似国自然基金

RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
  • 批准号:
    82371140
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
多孔Ti-MSNs@MGF+DX抗炎—成肌体系应用于颞下颌关节假体的作用和机制研究
  • 批准号:
    82370984
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
上皮祖细胞应答巨噬细胞分泌因子IL-1β参与炎症微环境下输卵管纤毛分化障碍的机制研究
  • 批准号:
    82371691
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
  • 批准号:
    82372120
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Caspase8和RIP3调控细胞程序性坏死的关键机制研究
  • 批准号:
    31970688
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
炎症因子调控干眼病眼表黏蛋白表达的分子机制
  • 批准号:
    81100636
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
TRAM基因选择性调控LPS失控性炎症反应的实验研究
  • 批准号:
    81071588
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目

相似海外基金

Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
囊性纤维化中的促炎干细胞变异体
  • 批准号:
    10367503
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
Development of pro-inflammatory treatment by cross-sectional control of aging lung metabolism and epigenetics
通过横断面控制衰老肺代谢和表观遗传学开发促炎治疗
  • 批准号:
    22K08250
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
囊性纤维化中的促炎干细胞变异体
  • 批准号:
    10557166
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
Pro-inflammatory Pyroptotic Cell Death in Aortic Degeneration
主动脉变性中的促炎焦亡细胞死亡
  • 批准号:
    10643934
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Multi-target suppression of pro-inflammatory cytokines using engineered targeted ribonucleases
使用工程化靶向核糖核酸酶多靶点抑制促炎细胞因子
  • 批准号:
    10282169
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
肿瘤内皮细胞对促转移纤维蛋白基质的调节
  • 批准号:
    10356164
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Pro-inflammatory Pyroptotic Cell Death in Aortic Degeneration
主动脉变性中的促炎焦亡细胞死亡
  • 批准号:
    10435503
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Mechanisms regulating the formation of a pro-metastatic niche and tumor cell dormancy in the liver
肝脏中促转移微环境的形成和肿瘤细胞休眠的调节机制
  • 批准号:
    10395452
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
肿瘤内皮细胞对促转移纤维蛋白基质的调节
  • 批准号:
    10179715
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Pro-inflammatory Pyroptotic Cell Death in Aortic Degeneration
主动脉变性中的促炎焦亡细胞死亡
  • 批准号:
    10237565
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了